Monoclonal Mouse anti‑Human IRAK1 / IRAK Antibody (Biotin, aa530‑693, IF, WB) LS‑C225689
Monoclonal Mouse anti‑Human IRAK1 / IRAK Antibody (Biotin, aa530‑693, IF, WB) LS‑C225689
Antibody:
IRAK1 / IRAK Mouse anti-Human Monoclonal (aa530-693) (Biotin) Antibody
Application:
IF, WB, ELISA
Format:
Biotin, Unmodified
Overview
Antibody:
IRAK1 / IRAK Mouse anti-Human Monoclonal (aa530-693) (Biotin) Antibody
Application:
IF, WB, ELISA
Format:
Biotin, Unmodified
Specifications
Description
IRAK antibody LS-C225689 is a biotin-conjugated mouse monoclonal antibody to human IRAK (IRAK1) (aa530-693). Validated for ELISA, IF and WB.
Target
Human IRAK1 / IRAK
Synonyms
IRAK1 | IRAK-1 | Pelle | Il1rak | IRAK | Pelle homolog
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2a,k
Monoclonal
Purification
Immunoaffinity purified
Immunogen
Recombinant protein corresponding to aa530-693 of human IRAK1.
Specificity
Human IRAK1 / IRAK.
Applications
- Immunofluorescence
- Western blot
- ELISA
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Storage
May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Mouse
Applications:
Western blot, Flow Cytometry
Species:
Human, Mouse
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
Positive/Negative
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/26/2024